Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079911 · ClinicalTrials.gov registry record · Phase 4
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
A Phase 4 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT00079911: Clinical Trial Phase 4 study, sponsored by GlaxoSmithKline.
NCT00079911 is a Phase 4 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00079911, a Phase 4 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This clinical research study will be an international trial evaluating the safety and effectiveness of a marketed drug compared to placebo (like a sugar pill) for the suppression of repeated genital herpes infections in HIV-infected subjects with CD4+ count \<100 cells/mm3.
Primary Outcome
The nature and incidence of adverse events, by treatment group, reported during the 6-month study will be summarized.
Interventions
- DRUG valacyclovir hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2004-03-12 |
| Est. Completion | 2004-10-15 |
| Phase | Phase 4 |
Why NCT00079911 stopped before completion
NCT00079911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which valacyclovir hydrochloride is the first listed.
NCT00079911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00079911 about?
NCT00079911 is a clinical study titled "A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons". This clinical research study will be an international trial evaluating the safety and effectiveness of a marketed drug compared to placebo (like a sugar pill) for the suppression of repeated genital herpes infections in HIV-infected subjects with CD4+ count \<100 cells/mm3.
What is the current status of trial NCT00079911?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2004-03-12. Estimated completion is 2004-10-15.
What interventions are being tested in trial NCT00079911?
The interventions under investigation include: valacyclovir hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00079911?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00079911's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI